相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Coronary Microvascular Dysfunction Clinical Considerations and Noninvasive Diagnosis
Thomas H. Schindler et al.
JACC-CARDIOVASCULAR IMAGING (2020)
Caspases in Cell Death, Inflammation, and Pyroptosis
Sannula Kesavardhana et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Statin ameliorates adipose inflammation via NLRP3 suppression
Min Tong et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Metformin protects against ischaemic myocardial injury by alleviating autophagy-ROS-NLRP3-mediated inflammatory response in macrophages
Qin Fei et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload
Junyan Wang et al.
CELL DEATH & DISEASE (2020)
Computationally modeling mammalian succinate dehydrogenase kinetics identifies the origins and primary determinants of ROS production
Neeraj Manhas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
NLRP3 inflammasome in endothelial dysfunction
Baochen Bai et al.
CELL DEATH & DISEASE (2020)
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang Yang et al.
CELL DEATH & DISEASE (2019)
NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy
Negin Parsamanesh et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1/RAGE/cathespin B signaling pathway and NLRP3 inflammasome activation
Chang Jia et al.
CELL DEATH & DISEASE (2019)
Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension
Shalini M. Krishnan et al.
CARDIOVASCULAR RESEARCH (2019)
The NLRP3 inflammasome in acute myocardial infarction
Stefano Toldo et al.
NATURE REVIEWS CARDIOLOGY (2018)
Liraglutide attenuates NLRP3 inflammasome-dependent pyroptosis via regulating SIRT1/NOX4/ROS pathway in H9c2 cells
Ao Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation
Chunxia Yao et al.
CIRCULATION (2018)
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Alena Grebe et al.
CIRCULATION RESEARCH (2018)
Coronary microembolization and microvascular dysfunction
Gerd Heusch et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
Soichi Sano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Succinate Dehydrogenase Complex An Updated Review
Mohamed Rizwan Haroon Al Rasheed et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Progressive waves of IL-1β release by primary human monocytes via sequential activation of vesicular and gasdermin D-mediated secretory pathways
Claudia Semino et al.
CELL DEATH & DISEASE (2018)
Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials
Suzanne de Waha et al.
EUROPEAN HEART JOURNAL (2017)
Statins Attenuate Activation of the NLRP3 Inflammasome by Oxidized LDL or TNFα in Vascular Endothelial Cells through a PXR-Dependent Mechanism
Shaolan Wang et al.
MOLECULAR PHARMACOLOGY (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pleiotropic Effects of Statins on the Cardiovascular System
Adam Oesterle et al.
CIRCULATION RESEARCH (2017)
Coronary microvascular obstruction in acute myocardial infarction
Giampaolo Niccoli et al.
EUROPEAN HEART JOURNAL (2016)
Establishment of a Novel Mouse Model of Coronary Microembolization
Yuan-Yuan Cao et al.
CHINESE MEDICAL JOURNAL (2016)
Mitochondria in the Regulation of Innate and Adaptive Immunity
Samuel E. Weinberg et al.
IMMUNITY (2015)
Coronary Microvascular Dysfunction, Microvascular Angina, and Treatment Strategies
Mark A. Marinescu et al.
JACC-CARDIOVASCULAR IMAGING (2015)
Coronary microvascular dysfunction: mechanisms and functional assessment
Paolo G. Camici et al.
NATURE REVIEWS CARDIOLOGY (2015)
NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin
Mamoru Satoh et al.
CLINICAL SCIENCE (2014)
TNF-α-induced cardiomyocyte apoptosis contributes to cardiac dysfunction after coronary microembolization in mini-pigs
Zhang-Wei Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Cardiovascular remodelling in coronary artery disease and heart failure
Gerd Heusch et al.
LANCET (2014)
MITOCHONDRIAL REACTIVE OXYGEN SPECIES (ROS) AND ROS-INDUCED ROS RELEASE
Dmitry B. Zorov et al.
PHYSIOLOGICAL REVIEWS (2014)
NLRP3 in myocardial ischaemiareperfusion injury: inflammasome-dependent or -independent role in different cell types
Masafumi Takahashi
CARDIOVASCULAR RESEARCH (2013)
The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemiareperfusion injury
Oystein Sandanger et al.
CARDIOVASCULAR RESEARCH (2013)
Effect of Atorvastatin (Lipitor) on Myocardial Apoptosis and Caspase-8 Activation Following Coronary Microembolization
Lang Li et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2011)
A role for mitochondria in NLRP3 inflammasome activation
Rongbin Zhou et al.
NATURE (2011)
The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
Eleonora Mezzaroma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Jurg Tschopp et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction
Marieke L. Fokkema et al.
EUROPEAN HEART JOURNAL (2009)
Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis
Ramanna Merla et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure
Valerio Zaca et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization
M Canton et al.
EUROPEAN HEART JOURNAL (2006)
Distal embolization during primary angioplasty: Histopathologic features and predictability
U Limbruno et al.
AMERICAN HEART JOURNAL (2005)
Beneficial cardiovascular pleiotropic effects of statins
J Davignon
CIRCULATION (2004)
Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction
JPS Henriques et al.
EUROPEAN HEART JOURNAL (2002)
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention - A randomized controlled trial
PWJC Serruys et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
分享论文
